Activity Available: April 2024 – April 2026

Education Activity Description: Listen to ISTAART voices, a new offering from the Alzheimer’s Association the International Society to Advance Alzheimer Research and Treatment (ISTAART). ISTAART Voices navigates the intricate world of dementia research and treatment in conversation with the researchers who are shaping the field.

Jointly provided by Postgraduate Institute for Medicine and Alzheimer’s Association

Estimated time to complete activity: Approximately 30 minutes per episode (.25 Credits)

Learning Objectives:

Episode 1

Discuss the link between culture and health
Discuss strategies to address and eliminate underrepresentation of minorities in research
Understand the current data regarding underrepresentation of minorities in dementia care research

Episode 2

Discuss inflammation as a key driver of sporadic Alzheimer's disease
Discuss the impact of GCPII inhibition is a novel strategy to help prevent tau pathology at early stages
Understand GCPII inflammatory signaling in brain decreases mGluR3 regulation of calcium

Episode 3

Discuss the link between community disadvantage and let-life cognition.
Understand the Inverse probability weightedmodels estimated expected mean differences in cognition/cognitive change attributed to residing in less advantaged communities

Episode 4

Discuss the link between genetics and Alzheimer's and dementia
Disscuss strategies to design better treatment for individals with down syndrome

Episode 5

Understand the differences in  frequencies of the top 10 Alzheimer's disease (AD) risk alleles for late-onset AD in Mexican American (MA) and non-Hispanic White (NHW) American
Discuss significant differences in frequencies of top AD risk alleles observed here across MAs and NHWs suggest that ethnicity-specific genetic risks for AD exist.

Episode 6

Discuss the importance of targeted recruitment strategies in maximizing participation in dementia clinical trials.

Episode 7

Discuss the increased risk of dementia prevalence in women with hearing loss.

Faculty Disclosure Information

Episode 1: Sharon Sanz Simon, PhD, Neuropsychologist, Associate Research Scientist at Cognitive Neuroscience Division, Taub Institute, Columbia University Irving Medical Center has nothing to disclose

Episode 2: Shveta Bathla, PhD, Psychiatry Department,Yale/ NIDA Neuroproteomics Center Yale school of medicine as nothing to disclose

Episode 3Rachel Peterson PhD, Assistant Professor, Univerity of Montana has nothing to disclose

Episode 4: Carlos Cruchaga PhDProfessor, Washington University School of Medicine has disclosed consulting relationships with AD Mit and Circular Genomics

Episode 5
Robert Barber PhDProfessor, University of North Texas Health Science Center has disclosed a grant relationship with NIH;
Mohammad Housini, MS, DO/PhD CandidateProfessor, University of North Texas Health Science Center has disclosed a grant relationship with NIH

Episode 6
Ellen Binder, MDGeriatrician, Washington University has nothing to disclose
Amanda N. Szabo-Reed, PhD, Associate Research Professor, University of Kansas Medical Center has nothing to disclose

Episode 7
Judy Pa, PhDProfesser, University of California, San Diego has nothing to disclose
Megan C. Fitzhugh, PhD, Post-Doctoral Candidate, University of California, San Diego has nothing to disclose

Accreditation Information

Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development.  The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Target Audience: This activity is intended to meet the educational needs of primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia.

Statement of Purpose: A practice gap is the difference between what healthcare professionals should or could be doing and what they are currently doing. Using current evidence based to bridge the gap between patient care and care recommendation, ensuring healthcare professionals are not only aware of current practice but are utilizing them in patient care settings. 

Joint Accreditation

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Alzheimer's Association.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designations:

Physician Continuing Medical Education; The Postgraduate Institute for Medicine designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™ per episode. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education: The maximum number of hours awarded for this Continuing Nursing Education activity is .25 contact hours per episode. This activity is being presented without bias and without commercial support.

For additional questions please contact clinical education staff at